Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...
Hims and other telehealth companies make finasteride easy to get and don’t have to disclose side effects in ads.
In recent years, telehealth companies like Hims and Keeps have revolutionized access to hair loss treatments by offering ...
Believe it or not, there's something worse than male pattern baldness. It's depression, plunging libido and shrinking ...
Telehealth companies like Hims & Hers (HIMS) are aggressively marketing hair-loss medications to young men, with some patients saying they ...
Apostrophe, a Bay Area telehealth company focused on skin care, shut down after almost four years under the Hims & Hers ...
Hims & Hers Health ( NYSE: HIMS) shut down Apostrophe on Friday, the skincare business it acquired in 2019 for $190M. A ...
Hims & Hers Health (NYSE: HIMS) has been a top healthcare stock to own over the past five years, soaring by around 350% ...
Hims Topical Finasteride & Minoxidil Spray is ... this specific product isn’t FDA-approved. Thinning hair and hair loss can occur for a variety of reasons. Determining the underlying cause ...
Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...
Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operation | Hims & Hers ...